会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Single-pass A-V pacing lead
    • 单程A-V起搏线
    • US5628779A
    • 1997-05-13
    • US629960
    • 1996-04-03
    • Gene A. BornzinKevin L. MorganJoseph J. FlorioWendy K. Wolsleger
    • Gene A. BornzinKevin L. MorganJoseph J. FlorioWendy K. Wolsleger
    • A61N1/05
    • A61N1/056
    • A single-pass atrio-ventricular (A-V) pacing lead includes an elongated main lead body having an atrial electrode at the distal end thereof, and includes a ventricular branch which departs from the main lead body just proximal to the tip of the atrial electrode. The ventricular branch has a ventricular electrode at its distal tip. The main lead body includes a preformed "J"-shaped portion which, following proper implantation, projects the atrial electrode against a wall of the atrial appendage. The ventricular branch includes a preformed bend which curves in the opposite direction of the J-shaped portion so as to maintain the ventricular branch generally away from the wall of the atrial appendage. The lead includes a single lumen which extends through both the main lead body and the ventricular branch, allowing the lead to be implanted using a single stylet. When the styler is fully inserted within the lumen, an extension portion of the atrial electrode, including the electrode tip, rests alongside the straightened ventricular branch so as to present a low cross-sectional profile, facilitating transvenous implantation.
    • 单通道心房(A-V)起搏引线包括细长的主引线体,其在其远端具有心房电极,并且包括心室分支,该心室分支离开主导体正好靠近心房电极的尖端。 心室分支在其远端具有心室电极。 主引线体包括预成形的“J”形部分,其在适当植入之后将心房电极投射到心房的壁上。 心室分支包括在J形部分的相反方向上弯曲的预成形弯曲部,以便使心室分支通常远离心房壁。 引线包括延伸穿过主引线主体和心室分支的单个内腔,允许使用单个通丝针植入引线。 当造型器完全插入管腔中时,包括电极末端的心房电极的延伸部分位于矫正的心室分支旁边,以便呈现低横截面轮廓,便于经静脉植入。
    • 2. 发明授权
    • Steerable obturator
    • 导向闭孔器
    • US07056314B1
    • 2006-06-06
    • US10452244
    • 2003-05-30
    • Joseph J. FlorioGene A. BornzinKevin L. MorganSheldon WilliamsJanice Barstad
    • Joseph J. FlorioGene A. BornzinKevin L. MorganSheldon WilliamsJanice Barstad
    • A61M25/01
    • A61M25/0152A61B17/3478A61B2017/003A61M25/0136A61M25/0141A61M25/0147A61M2025/015A61M2025/0161
    • An omnidirectionally steerable obturator facilitates the delivery of the distal tip of an introducer sheath into the coronary sinus of a heart. The steerable obturator comprises an obturator body extending longitudinally along a central axis, the obturator body being configured to be received by the introducer sheath. The obturator body further has a flexible, deflectable distal end section terminating in a rounded distal tip. An actuator, controllable from a proximal end of the obturator body, is operatively associated with the flexible distal end section of the obturator body to cause deflection of the flexible distal end section of the obturator body in at least one selected direction to facilitate passage of the distal end section of the obturator body and the distal tip of the introducer sheath into the coronary sinus of the heart.The obturator body is preferably configured to be received in a close fit within at least the tip of the introducer sheath. More preferably, the distal end of the obturator body has an outer surface and the fit between the outer surface of the obturator and at least the tip of the introducer sheath comprises substantially a line-to-line fit.
    • 全向可操纵的闭孔器有利于将导引鞘的远侧末端递送到心脏的冠状窦。 可操纵的闭孔器包括沿着中心轴线纵向延伸的闭孔器,所述封闭器主体构造成由引导器护套容纳。 闭孔体还具有终止于圆形远端尖端的柔性的,可偏转的远端部分。 从闭塞体的近端可控制的致动器与闭塞体的柔性远端部分可操作地相关联,以使闭塞体的柔性远端部分沿至少一个选定的方向偏转,以便于通过 闭塞体的远端部分和导引鞘的远侧末端插入心脏的冠状窦。 闭孔体优选构造成在至少引导器护套的尖端内紧密配合。 更优选地,闭孔体的远端具有外表面,并且填塞物的外表面与引导器护套的至少末端之间的配合基本上包括线对齐配合。
    • 4. 发明授权
    • Single pass telescoping cardiac lead for the left heart
    • 单通伸缩心脏线为左心
    • US06988007B1
    • 2006-01-17
    • US10218353
    • 2002-08-13
    • Kevin L. MorganGene A. BornzinJoseph J. FlorioJohn R. Helland
    • Kevin L. MorganGene A. BornzinJoseph J. FlorioJohn R. Helland
    • A61N1/05
    • A61N1/056A61N1/057A61N2001/0585
    • An implantable single-pass cardiac stimulation lead provides for placement of electrodes into electrical contact with two chambers of a patient's heart. The lead includes an inner lead body having at least one electrode at its distal end and an outer lead body having at least one electrode at its distal end. The outer lead body has an internal lumen that slidingly receives the inner lead body. The inner lead body is extendable from the outer lead body at a point proximal to the distal end of the outer lead body. The sliding of the inner lead body relative to the outer lead body enables the inner lead body distal electrode to have a varying distance from the outer lead body distal electrode and enables the inner lead body to extend into the coronary sinus region of the heart to place the inner lead body electrode into electrical contact with the left ventricle.
    • 可植入的单程心脏刺激引线提供将电极放置在与患者心脏的两个腔室电接触的位置。 引线包括在其远端具有至少一个电极的内引线体和在其远端具有至少一个电极的外引线体。 外引线体具有滑动地接收内引线体的内腔。 内引线体可以在外引线体的远离外引线体的远端的位置处延伸。 内引线体相对于外引线体的滑动能够使内引线体远端电极与外引线体远端电极间距离变化,能够使内引线体延伸到心脏的冠状窦区域 内部引线体电极与左心室电接触。
    • 5. 发明授权
    • Implantable cardiac single pass coronary sinus lead for providing pacing and defibrillation and method of manufacture
    • 可植入心脏单程冠状动脉窦导管用于提供起搏和除颤及其制造方法
    • US06490489B2
    • 2002-12-03
    • US09771505
    • 2001-01-26
    • Gene A. BornzinAnne M. PiancaKevin L. MorganJohn R. HellandJoseph J. Florio
    • Gene A. BornzinAnne M. PiancaKevin L. MorganJohn R. HellandJoseph J. Florio
    • A61N105
    • A61N1/056
    • A single chronic implantable cardiac lead for use in the coronary sinus region of the heart provides both atrial and ventricular pacing and defibrillation therapy. The lead includes an elongated lead body having a distal end and a proximal end, a first electrode assembly including a ventricular pacing electrode and a ventricular defibrillation at the distal end, a second electrode assembly proximal to the first electrode assembly including at least one atrial pacing electrode and an atrial defibrillation electrode, and a further defibrillation electrode proximal to the second electrode assembly. The electrode assemblies and further defibrillation electrode are spaced apart so that when the lead is implanted within the coronary sinus region of the heart with the first electrode assembly adjacent the left ventricle, the second electrode assembly is adjacent the left atrium and the further defibrillation electrode is within the right atrium and/or the superior vena cava.
    • 用于心脏冠状静脉窦区域的单一慢性可植入心脏线可提供心房起搏和除颤治疗。 引线包括具有远端和近端的细长引线主体,包括心室起搏电极和在远端处的心室除颤的第一电极组件,靠近第一电极组件的第二电极组件,包括至少一个心房起搏 电极和心房除颤电极,以及靠近第二电极组件的另外的除颤电极。 电极组件和另外的除颤电极间隔开,使得当铅被植入心脏的冠状窦区域内时,第一电极组件邻近左心室,第二电极组件邻近左心房,另外的除颤电极 在右心房和/或上腔静脉内。
    • 8. 发明授权
    • Methods and apparatus for overdrive pacing heat tissue using an implantable cardiac stimulation device
    • 使用可植入心脏刺激装置的超速起搏热组织的方法和装置
    • US06804556B1
    • 2004-10-12
    • US10036026
    • 2001-12-21
    • Joseph J. FlorioGene A. BornzinJohn W. PooreDouglas T. Kurschinski
    • Joseph J. FlorioGene A. BornzinJohn W. PooreDouglas T. Kurschinski
    • A61N1365
    • A61N1/368
    • Techniques are described for overdrive pacing the heart using a pacemaker wherein the overdrive pacing rate only increases when at least two intrinsic beats are detected within a determined search period. In one specific technique, an increase in the pacing rate occurs only if two P-waves are detected within X cardiac cycles. In another specific technique, the overdrive pacing rate is increased only if at least two P-waves are detected within a block of N cardiac cycles. In both techniques, the overdrive pacing rate is decreased if no increase has occurred in the last Z cardiac cycles. By increasing the overdrive pacing rate only in response to detection of at least two P-waves within a determined number of cardiac cycles, an excessively high overdrive pacing rate is avoided. Other techniques are described for adaptively adjusting overdrive pacing parameters so as to achieve a determined target degree of pacing of, for example, 95% paced beats. By adaptively adjusting overdrive parameters to maintain a target degree of pacing, the average overdrive pacing rate is minimized while still maintaining a high number of paced beats, thereby reducing the risk of a tachyarrhythmia occurring within the patient.
    • 描述了使用起搏器超速起搏心脏的技术,其中在确定的搜索周期内检测到至少两个固有节拍时,超速起搏速率仅增加。 在一种特定技术中,只有在X个心动周期内检测到两个P波时,起搏速率才会增加。 在另一个具体技术中,只有在N个心动周期的块内检测到至少两个P波时,才能增加超速起搏速率。 在两种技术中,如果在最后Z个心动周期中没有发生增加,则超速起搏速率将降低。 通过仅在确定的心跳周期内响应于至少两个P波的检测来增加超速起搏速率,避免了过高的超速起搏速率。 描述了用于自适应地调节过驱动起搏参数的其它技术,以便实现例如95%起搏节拍的确定的目标起搏程度。 通过自适应地调整过驱动参数以保持目标起搏程度,平均超速起搏速度最小化,同时仍然保持大量的起搏节奏,从而降低患者内出现快速性心律失常的风险。
    • 9. 发明授权
    • Method and apparatus for detecting natural electrical coherence within the heart and for administering therapy based thereon
    • 用于检测心脏内的自然电相干性并用于基于其进行治疗的方法和装置
    • US06766195B1
    • 2004-07-20
    • US09686630
    • 2000-10-10
    • Gene A. BornzinPeter BoileauJoseph J. FlorioJohn W. PooreKelly H. McClure
    • Gene A. BornzinPeter BoileauJoseph J. FlorioJohn W. PooreKelly H. McClure
    • A61N0118
    • A61N1/3962A61N1/395
    • Techniques are provided for detecting natural electrical coherence within the heart and for administering or adjusting therapy based upon whether natural electrical coherence is detected. In one example, an implantable cardioverter defibrillator (ICD), upon detecting atrial fibrillation, delays administering an atrial defibrillation pulse until a period of natural electrical coherence is detected between the left and the right atria of the heart. The ICD may further delay the pulse until the ventricles of the heart are refractory so as to help prevent triggering ventricular fibrillation. The pulses are administered at a time selected based upon the period of electrical coherence to reduce the amount of electrical energy required within the pulse to reliably defibrillate the heart. Other types of therapy besides defibrillation therapy such as anti-tachycardia pacing pulses may also be timed based upon detection periods of natural electrical coherence. Method and apparatus embodiments are described.
    • 提供了用于检测心脏内的自然电连贯性的技术,并且用于基于是否检测到自然电连贯来施用或调整治疗。 在一个实例中,在检测心房颤动时,植入式心律转复除颤器(ICD)延迟施用心房除颤脉冲,直到在心脏的左心房和右心房之间检测到自然电相干的时间段。 ICD可以进一步延迟脉冲,直到心脏的心室难以耐受,以便有助于防止触发心室颤动。 在基于电相干周期选择的时间施加脉冲以减少脉冲内所需的电能量以可靠地除颤心脏。 除了除颤疗法之外的其他类型的治疗,如抗心动过速起搏脉冲也可以基于自然电连续性的检测周期来计时。 描述了方法和设备实施例。
    • 10. 发明授权
    • Implantable cardiac stimulation system and method for automatic capture verification calibration
    • 植入式心脏刺激系统和自动捕获验证校准方法
    • US06731985B2
    • 2004-05-04
    • US09981555
    • 2001-10-16
    • John W. PooreKerry BradleyLaurence S. SlomanGene A. BornzinJoseph J. Florio
    • John W. PooreKerry BradleyLaurence S. SlomanGene A. BornzinJoseph J. Florio
    • A61N1362
    • A61N1/3712
    • An implantable cardiac stimulation device and associated method perform an automatic calibration procedure for evaluating whether automatic capture verification can be recommended. The calibration procedure calculates and displays a number of variables for use by a medical practitioner in programming automatic capture operating parameters. An average paced depolarization integral (PDI) is determined from the cardiac signals following delivery of multiple stimulation pulse below and above capture threshold such that both pure lead polarization signals and evoked response signals may be analyzed. From the paced depolarization integral data, a capture threshold, a stimulation response curve, a minimum evoked response, a maximum lead polarization, an evoked response sensitivity, an evoked response safety margin, and a polarization safety margin are determined. Based on these variables, the calibration procedure determines if automatic capture verification can be recommended. If so, the stimulation device calculates a capture detection threshold. The automatic capture verification recommendation and the estimated calibration variables are displayed.
    • 可植入心脏刺激装置和相关方法执行自动校准程序,以评估是否可以推荐自动捕获验证。 校准程序计算并显示许多变量,供医生在编程自动捕获操作参数时使用。 平均节奏去极化积分(PDI)是在多次刺激脉冲传递后低于和高于捕获阈值的心脏信号确定的,以便可以分析纯铅极化信号和诱发响应信号。 从起搏去极化积分数据中,确定捕获阈值,刺激响应曲线,最小诱发响应,最大引线极化,诱发响应灵敏度,诱发响应安全裕度和极化安全裕度。 基于这些变量,校准过程确定是否可以推荐自动捕获验证。 如果是,则刺激装置计算捕获检测阈值。 显示自动捕获验证建议和估计的校准变量。